Learn

MindMed, atai Life Sciences, Compass Pathways: A Psychedelic Stock Analysis
Our resident psychedelic investor explains a handful of important metrics to study when analyzing and comparing psychedelic stocks....
The history of MDMA is fascinating, and it is still being written....
This week in psychedelic business news: Beckley Retreats set launch; another shark swims into the psychedelics industry; and MindMed shares...
Researchers at PSYCH Symposium reveal promising results from double-blind, placebo-controlled study with 46 patients....
Psychedelic investors are about to see pivotal data presented on flagship programs by the titans of the psychedelics industry....
Psychedelic Spotlight's video producer attended the inaugural Benzinga Psychedelic Capital Conference, and here's what he walked away with....
This week in psychedelic business news: Wesana Health pivots strategy; Compass Pathways makes progress on anorexia; Completion launches psychedelic VR...
Wesana Health reaches a major strategic pivot point. Our resident Psychedelic Investor examines what this means for the company and...
There is currently no FDA-approved treatment for anorexia. Could psychedelics be the answer?...
Science just keeps discovering how cool and beneficial mushrooms are, with or without psilocybin....